The first pill to treat postpartum depression has been approved by U.S. health officials
1 year, 5 months ago

The first pill to treat postpartum depression has been approved by U.S. health officials

LA Times  

U.S. health officials have approved Zurzuvae, the first pill specifically intended to treat severe depression after childbirth. Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year. The new pill is from Sage Therapeutics, which has a similar infused drug that’s given intravenously over three days in a medical facility. Dr. Kimberly Yonkers, a psychiatrist at Yale University, said the Zurzuvae effect is “strong” and the drug likely will be prescribed for women who haven’t responded to antidepressants.

Depression Postpartum Depression Drug Fda Pill Severe Depression Zurzuvae Yonkers  pill  depression  treat  zurzuvae  days  postpartum  women  severe  yonkers  health  drug  officials  approved  childbirth

History of this topic

There's a new prescription pill for postpartum depression. How will coverage work?
9 months, 4 weeks ago

There's a new prescription pill for postpartum depression. How will coverage work?

NPR  

There's a new prescription pill for postpartum depression. Sponsor Message Kaiser Permanente's writtten guidelines required patients to try and fail four medications, and try electroconvulsive therapy, before they would be eligible for brexanolone. Enlarge this image toggle caption Keith McDonald Keith McDonald One month after NPR published its investigation, KP overhauled its criteria to recommend that women try just one …

US Health Officials Approve First Postpartum Depression Pill for New Mothers
1 year, 5 months ago

US Health Officials Approve First Postpartum Depression Pill for New Mothers

News 18  

Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year. “Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings,” said Dr. Tiffany Farchione, FDA’s director of psychiatric …

FDA approves the first drug designed to treat postpartum depression
5 years, 9 months ago

FDA approves the first drug designed to treat postpartum depression

LA Times  

Washington Post The Food and Drug Administration on Tuesday approved the first drug specifically for postpartum depression, a debilitating condition that affects about 400,000 women a year in the United States. Sage is developing another drug to treat postpartum depression and major depressive disorder that would be administered as a once-daily pill. The FDA’s advisory committee recommended approval of brexanolone …

Discover Related